DBV Technologies S.A. American Depositary Shares (DBVT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for DBV Technologies S.A. American Depositary Shares, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
DBV Technologies S.A. American Depositary Shares (DBVT) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $600M. It trades at $10.65, up 5.19% today. Its overall quality score is 27 out of 100, ranked against the whole US market. 2 analysts' average target of $42.50 implies +299.1% from today's price. Kronos AI's 30-day forecast is +29.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $42.50 |
| Low – high | $40.00 – $45.00 |
| Analysts | 2 |
| Upside to average | +299.1% |
Kronos AI 30-day forecast
| Expected close | $13.10 (+29.4%) |
| Likely range | +18.6% … +47.3% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 4 |
| Solvency | 54 |
| Growth | 22 |
| Overall | 27 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |